Opinion Review
Copyright ©The Author(s) 2022.
World J Clin Pediatr. Mar 9, 2022; 11(2): 93-104
Published online Mar 9, 2022. doi: 10.5409/wjcp.v11.i2.93
Table 1 Advantages and disadvantages of nitrous oxide use for anesthesia
Advantages
Disadvantages
Analgesia Low potency
Reduced awareness Risk of diffusion hypoxia
Colorless and odorlessPONV [risk ratio 1.21 (CI: 1.04-1.40); P = 0.014]2
Inexpensive (Rs 50/patient)1Ability to expand air filled cavities
Faster onset and emergence (elimination half-life 5 min)Increases cuff pressure of ETT and LMA
Minimal metabolism (< 0.004%)Hematological/neurological toxicity
Cardiorespiratory stability Immune deficiency?
Prevents CPSP Reproductive effects
Treatment-resistant refractory depressionMyocardial ischemia?
Greenhouse gas
Apoptosis in developing brains
Table 2 Systemic effects of nitrous oxide
Respiratory systemDecreases tidal volume and respiratory rate
Reduced ventilatory response to carbon dioxide and hypoxia
Central nervous systemLoss of awareness
Analgesia
Increased cerebral blood flow and intracranial pressure
(Concentration > 70%)
Cardiovascular systemSympathomimetic
Direct myocardial depression
Hemodynamic effectsCombination with other inhalational agents reduce the incidence of hypotension when compared to administration of the agents alone
Table 3 Summary of results of the key clinical trials and systematic reviews in relation to use of nitrous oxide as a component of anesthesia
Trial
Ref.
Main findings
ENIGMA TrialMyles et al[26], 2007Increased rates of major complications (OR: 0.71; 95%CI: 0.56-0.89; P = 0.003) myocardial infarction, stroke, pneumonia, pulmonary embolism, wound infection, severe PONV (OR: 0.40; 95%CI: 0.31-0.51; P < 0.001), and death.
ENIGMA II TrialMyles et al[27], 2014Risk of death at 1 year, cardiovascular complications (combined RR for death and cardiovascular complications was 0.96, 95%CI: 0.83-1.12; P = 0.64) or surgical-site infection in the nitrous oxide group not increased (P = 0.61). Risk of PONV was reduced by one third in the patients not exposed to nitrous oxide (P < 0.0001), but the absolute risk reduction was only 4%.
A large retrospective analysis of registriesTuran et al[28], 2013Patients receiving nitrous oxide had 40% lower risk of pulmonary complication (OR: 95% Bonferroni-adjusted CI: 0.59, 0.44-0.78) and death (OR: 97.5%CI: 0.67, 0.46-0.97; P = 0.02), while cardiovascular complications were comparable.
Cochrane review on complications with use of nitrous oxideSun et al[29], 2015Nitrous oxide increased the incidence of pulmonary atelectasis (OR: 1.57, 95%CI: 1.18-2.10, P = 0.002) but had no effects on the rates of in-hospital mortality, pneumonia, myocardial infarction, stroke, venous thromboembolism, wound infection, or length of hospital stay.
Cochrane review on accidental awareness with use of nitrous oxide Hounsome et al[30], 2016Despite the inclusion of 3520 participants, only three awareness events were reported by two studies. In one study the event was due to technical failure. Due to the low quality of evidence, the authors could not determine whether the use of nitrous oxide in general anesthesia increases, decreases, or has no effect on the risk of accidental awareness.
Table 4 Summary of various trials on use of nitrous oxide for alleviation of procedural pain and sedation in children
Ref.
Main study objective
Setting/procedures
Number of children; Age
Findings
Babl et al[43], 2008 Depth of sedation and incidence of adverse effects with various N2O concentrationsPediatric ER procedures762; 1-17 yrN2O in high concentration (70%) and continuous flow was found to be a safe agent for procedural sedation and analgesia in toddlers and older children
Babl et al[44], 2010 Sedation practices and the associated adverse events profile Procedural sedation and analgesia from registry database at the largest Australian pediatric ER of a children’s hospital 2002; 1-17 yrN2O was used in majority cases (81%), and incidence of serious adverse events was low. (desaturation, n = 2; seizures, n = 2, and chest pain, n = 1)
Brown et al[45], 2009 Evaluate the PediSedate (a N2O delivery system combined with an interactive video component) for reducing children’s behavioral distress Children who received the PediSedate before invasive procedures 40; 3-9 yrPediSedate is an effective system for procedural sedation in children
Ekbom et al[46], 2011 To find out whether oral midazolam or 50% N2O, or 10% N2O; along with lidocaine/prilocaine ointment is most effective in gaining IV access in obese or growth retarded children Children and adolescents undergoing IV access at a Children’s Hospital in Stockholm, Sweden90; 5-18yr50% N2O resulted in an improved rate of IV access, a shorter procedure time, and a better experience for these children
Jimenez et al[47], 2012 Comparison of N2O and hematoma block with and without trans-mucosal fentanyl for sedation and analgesia in the reduction of radioulnar fractures.Retrospective, observational study, in children with radioulnar fractures in a pediatric ER81; 4-15 yrThe combination of all 3 agents in pediatric ER improved analgesia compared with only N2O and hematoma block combination
Lee et al[48], 2012Comparison of the sedaoanalgesia profile of N2O vs IV ketamine Prospective, randomized study at ER of a single academic center in children undergoing primary repair of a laceration wound 32; 3-10 yrN2O was found preferable to ketamine because it provides a faster recovery, is safe, and maintains a suitable safe plane of sedation
Srinivasan et al[49], 2013 Determine the effectiveness and safety of procedural sedation performed using ketamine (0.5-1 mg/kg) or N2O (50%-70%). Retrospective review and analysis of a quality improvement database for procedural sedations performed at St Louis Children’s Hospital undergoing sedation by pediatric hospitalists 8870; 7 mo to 4 yrCombination of ketamine and N2O provides lowest rates of complications. Respiratory and cardiovascular events occurred more frequently with ketamine, whereas NV, sedation level not achieved, and procedure not completed were more frequent with N2O